Current usage of tumor treating fields for glioblastoma.
Andrew B LassmanAdela E Joanta-GomezPeter C PanWolfgang WickPublished in: Neuro-oncology advances (2020)
Providers continue to view TTF with some level of skepticism, with a lack of additional supportive data and logistical concerns representing continued barriers to uptake.